Chenxi P. Cao
Jiaxing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Cordycepin Alleviates Non Alcoholic Fatty Liver Disease Progression by Stabilizing GCH1 to Inhibit Ferroptosis.
Journal: Phytotherapy research : PTR
Published: May 26, 2026
Targeting RPRD1B overcomes chemoresistance in gastric cancer by suppressing the TOPBP1-mediated DNA damage repair pathway.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 30, 2025
Tumor-suppressing multi-enterobacteria and PD-1/PD-L1 immune checkpoint inhibitor combination improves the outcome of hepatocellular carcinoma therapy.
Journal: Frontiers in immunology
Published: March 23, 2025
Activation of mechanosensitive ion channel Piezo1 linking metabolic reprogramming and pro-inflammatory responses in hepatocellular carcinoma.
Journal: Cell communication and signaling : CCS
Published: February 14, 2025
A study of correlation of the dietary index for gut microbiota with non-alcoholic fatty liver disease based on 2007-2018 National Health and Nutrition Examination Survey.
Journal: Frontiers in nutrition
Published: February 08, 2025
Toxicological Mechanism of Triptolide-Induced Liver Injury.
Journal: Journal of biochemical and molecular toxicology
Published: January 18, 2025
TFAP4 regulates the progression of liver fibrosis through the STING signaling pathway.
Journal: International immunopharmacology
Published: December 06, 2024
Cell-Cycle-Related and Expression Elevated Protein in Tumor Upregulates the Antioxidant Genes via Activation of NF-κB/Nrf2 in Acute Liver Injury.
Journal: Toxics
Published: November 05, 2024
Cross-Talk between NOK and EGFR: Juxtamembrane and Kinase domain interactions enhancing STAT3/5 signaling in breast cancer tumorigenesis.
Journal: Translational oncology
Published: October 07, 2024
Swertianin Promotes Anti-Tumor activity by facilitating Macrophage M1 polarization via STING signaling.
Journal: International immunopharmacology
Published: August 26, 2024
An oncoprotein CREPT functions as a co-factor in MYC-driven transformation and tumor growth.
Journal: The Journal of biological chemistry
Published: August 14, 2024
Last Updated: 09/26/2026